Marc Lesnick is a seasoned regulatory affairs professional with extensive experience across various organizations in the biopharmaceutical industry. They served as the Chief Development Officer at Tris Pharma and held leadership roles including Sr. VP at companies such as QED Therapeutics and Cascadian Therapeutics. Marc began their career as a Regulatory Affairs Intern at Skyepharma and advanced through positions such as Consultant at PAREXEL and Scientific Review Administrator at NIAID/NIH. They earned a Ph.D. from the University of Oregon and a B.A. from the University of California, Santa Cruz. Currently, Marc holds the position of Vice President of Regulatory Affairs at AbCellera.
This person is not in any offices